|
LTA4H expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.516800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.065800E-01 |
| Normal-vs-Stage2 |
5.747800E-02 |
| Normal-vs-Stage3 |
5.059400E-01 |
| Normal-vs-Stage4 |
9.911600E-02 |
| Stage1-vs-Stage2 |
1.853790E-01 |
| Stage1-vs-Stage3 |
8.511000E-01 |
| Stage1-vs-Stage4 |
8.668300E-02 |
| Stage2-vs-Stage3 |
1.637430E-01 |
| Stage2-vs-Stage4 |
5.554000E-01 |
| Stage3-vs-Stage4 |
1.674560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.795600E-02 |
| Normal-vs-AfricanAmerican |
1.068400E-02 |
| Normal-vs-Asian |
3.869600E-01 |
| Caucasian-vs-AfricanAmerican |
2.411800E-01 |
| Caucasian-vs-Asian |
5.336600E-01 |
| AfricanAmerican-vs-Asian |
8.395800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.638300E-02 |
| Normal-vs-Female |
1.182630E-03 |
| Male-vs-Female |
3.870000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.572040E-01 |
| Normal-vs-Extreme_Weight |
4.715400E-01 |
| Normal-vs-Obese |
6.950100E-02 |
| Normal-vs-Extreme_Obese |
1.122380E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.286600E-01 |
| Normal_Weight-vs-Obese |
7.772800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.907700E-02 |
| Extreme_Weight-vs-Obese |
2.442800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.061000E-01 |
| Obese-vs-Extreme_Obese |
9.963900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.724410E-02 |
| Normal-vs-Age(41-60Yrs) |
1.986340E-02 |
| Normal-vs-Age(61-80Yrs) |
1.055230E-01 |
| Normal-vs-Age(81-100Yrs) |
2.709600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.389800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.197700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.063400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.314400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.497000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.923200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.850000E-02 |
| Normal-VS-Type2 PRCC |
3.275600E-01 |
| Normal-VS-KIRP CIMP |
1.181670E-02 |
| Normal-VS-Unclassified PRCC |
3.016100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.574400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.410110E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.296800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.620900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.257380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.683400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.018200E-01 |
| Normal-vs-N1 |
2.261900E-02 |
| Normal-vs-N2 |
2.939100E-03 |
| N0-vs-N1 |
3.242100E-02 |
| N0-vs-N2 |
1.499350E-01 |
| N1-vs-N2 |
7.879600E-01 |
|
|
